Keynote-föreläsare

Willem A. Bemelman graduated as a surgeon in 1994 trained at the department of Surgery of the Academic Medical Hospital, University of Amsterdam and St. Lucas Hospital in Amsterdam. After his training as a surgeon, he worked at the department of Surgery at Leiden University Medical Center being responsible for the benign gastrointestinal disease. In 1999 he returned to the Academic Medical Center to develop the Minimal Invasive Surgery further. In 2006 he was appointed as a Professor in Surgery. Parallel to his appointment at the Amsterdam University Medical Centers, he worked parttime at the San Raffaele Ospedale in Milan from 2021-2022.

His field of interest in patient care and research is the (minimal invasive)treatment of IBD, colorectal cancer and complication surgery.

Bemelman is a EBSQ certified colorectal surgeon (Bologna 2005), the former president of the ESCP (2019-2020) and former secretary of ECCO (2018-2020). He has more than 675 pubmed papers, coached more than 50 PhD students and has a H-index of 79. He holds honorary memberships of 10 international societies, and is a member of the IOIBD
and Europeans Surgical Association.

Currently he is working in the department of surgery of the Amsterdam University Medical Centers and parttime at Bento Surgical Clinics.

Jonas F. Ludvigsson är barnläkare vid Universitets­sjukhuset Örebro, professor i klinisk epidemiologi vid Karolinska Institutet samt adjungerad professor vid Columbia University, New York, USA.

Jonas har publicerat över 600 vetenskapliga artiklar, inklusive i New England J Medicine, Lancet, JAMA samt BMJ och han har återkommande listats som en av Sveriges mest citerade forskare.

Jonas är för närvarande vetenskaplig sekreterare i Svenska Läkaresällskapet och tilldelades 2024 Hans majestät konungens medalj i 8e storleken i Serafimerordens band för sin forskning.

Under våren 2025 utkommer hans nya bok ”Att börja forska inom medicin och hälsa” (Studentlitteratur). På Gastrodagarna 2025 ger Jonas en högtidsföreläsning till minne av Anders Ekbom, som var Jonas opponent, mentor och vän.  När Ekbom avled förra året tog Jonas initiativ till två minnesord. (1, 2)

1. Ludvigsson JF, Askling J, Cnattingius S, Hall P, Klareskog L, Nyren O, Baron JA, Sørensen HT. Obituary – Anders Ekbom. Clin Epidemiol. 2024;16:567-569
2. Ludvigsson, J.F., Lagerros, Y.T. & Akre, O. Anders Ekbom: Swedish physician and epidemiologist 1947–2024. Eur J Epidemiol 39, 1207–1209 (2024).

Coordinator, French National Filfoie Network for rare liver diseases, and of the reference Center for Vascular Liver Diseases

Hôpital Beaujon, Clichy, France

Dr. Aurélie Plessier is a hepatologist with special interest in vascular liver diseases and portal hypertension. She is the coordinator of the French National Reference Center for Vascular Liver Diseases at Hôpital Beaujon, a premier institution recognized for its expertise in rare hepatic vascular disorders. She is also the coordinator of the French National Filfoie Network for rare liver diseases https://www.filfoie.com/

With a PhD in Physiology and Physiopathology from Université Paris Cité, Dr. Plessier has contributed to major European and national research initiatives, including more recently the EJPRD LIVES Project focused on improving the quality of life for patients with vascular liver diseases.

Dr. Plessier’s publications, with H-index of 51, have significantly influenced European and national clinical guidelines in vascular liver disease. She is an Associate Editor for the Journal of Hepatology, a board member of VALDIG Vascular Liver Disease Group( https://www.valdig.eu/ ), IRCPSS International Registry of Congenital Portosystemic Shunts group (https://ircpss.com/ ), ERN Rare Liver, and the French Association for the Study of the Liver (AFEF), and a member of the European Association for the Study of the Liver (EASL).

Beyond research and clinical practice, Dr. Plessier is deeply committed to medical education and patient advocacy. She has developed innovative educational tools, including smartphone app and educational films designed to support patients living with vascular liver diseases.